Woods JH - Search Results

1

Constitutive activity of the delta-opioid receptor expressed in C6 glioma cells: identification of non-peptide delta-inverse agonists.

Neilan CL, Akil H, Woods JH, Traynor JR. Neilan CL, et al. Among authors: woods jh. Br J Pharmacol. 1999 Oct;128(3):556-62. doi: 10.1038/sj.bjp.0702816. Br J Pharmacol. 1999. PMID: 10516632 Free PMC article.

2

Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats.

Jutkiewicz EM, Eller EB, Folk JE, Rice KC, Traynor JR, Woods JH. Jutkiewicz EM, et al. Among authors: woods jh. J Pharmacol Exp Ther. 2004 Apr;309(1):173-81. doi: 10.1124/jpet.103.061242. Epub 2004 Jan 13. J Pharmacol Exp Ther. 2004. PMID: 14722329

3

Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.

Neilan CL, Husbands SM, Breeden S, Ko MC, Aceto MD, Lewis JW, Woods JH, Traynor JR. Neilan CL, et al. Among authors: woods jh. Eur J Pharmacol. 2004 Sep 19;499(1-2):107-16. doi: 10.1016/j.ejphar.2004.07.097. Eur J Pharmacol. 2004. PMID: 15363957

4

Comparison of peptidic and nonpeptidic delta-opioid agonists on guanosine 5'-O-(3-[35S]thio)triphosphate ([35S]GTPgammaS) binding in brain slices from Sprague-Dawley rats.

Jutkiewicz EM, Walker NP, Folk JE, Rice KC, Portoghese PS, Woods JH, Traynor JR. Jutkiewicz EM, et al. Among authors: woods jh. J Pharmacol Exp Ther. 2005 Mar;312(3):1314-20. doi: 10.1124/jpet.104.078741. Epub 2004 Dec 1. J Pharmacol Exp Ther. 2005. PMID: 15574687 Free PMC article.

5

BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.

Husbands SM, Neilan CL, Broadbear J, Grundt P, Breeden S, Aceto MD, Woods JH, Lewis JW, Traynor JR. Husbands SM, et al. Among authors: woods jh. Eur J Pharmacol. 2005 Feb 21;509(2-3):117-25. doi: 10.1016/j.ejphar.2004.12.035. Eur J Pharmacol. 2005. PMID: 15733546

6

Differential behavioral tolerance to the delta-opioid agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in Sprague-Dawley rats.

Jutkiewicz EM, Kaminsky ST, Rice KC, Traynor JR, Woods JH. Jutkiewicz EM, et al. Among authors: woods jh. J Pharmacol Exp Ther. 2005 Oct;315(1):414-22. doi: 10.1124/jpet.105.088831. Epub 2005 Jul 13. J Pharmacol Exp Ther. 2005. PMID: 16014751 Free PMC article.

7

Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey.

Ko MC, Divin MF, Lee H, Woods JH, Traynor JR. Ko MC, et al. Among authors: woods jh. J Pharmacol Exp Ther. 2006 Feb;316(2):772-9. doi: 10.1124/jpet.105.094409. Epub 2005 Oct 28. J Pharmacol Exp Ther. 2006. PMID: 16258020

8

Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice.

Broom DC, Nitsche JF, Pintar JE, Rice KC, Woods JH, Traynor JR. Broom DC, et al. Among authors: woods jh. J Pharmacol Exp Ther. 2002 Nov;303(2):723-9. doi: 10.1124/jpet.102.036525. J Pharmacol Exp Ther. 2002. PMID: 12388657

9

Behavioral effects of delta-opioid receptor agonists: potential antidepressants?

Broom DC, Jutkiewicz EM, Rice KC, Traynor JR, Woods JH. Broom DC, et al. Among authors: woods jh. Jpn J Pharmacol. 2002 Sep;90(1):1-6. doi: 10.1254/jjp.90.1. Jpn J Pharmacol. 2002. PMID: 12396021 Free article. Review.

10

Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the mu opioid receptor.

Emmerson PJ, Clark MJ, Mansour A, Akil H, Woods JH, Medzihradsky F. Emmerson PJ, et al. Among authors: woods jh. J Pharmacol Exp Ther. 1996 Sep;278(3):1121-7. J Pharmacol Exp Ther. 1996. PMID: 8819494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

457 results

Search Page